De novo fatty acid biosynthesis and HIV replication

NIH RePORTER · NIH · R21 · $230,248 · view on reporter.nih.gov ↗

Abstract

ABSTRACT HIV-1 commandeers host metabolism to create a cellular environment favorable to viral replication. We have recently discovered that mammalian fatty acid synthase (FASN) levels increase following HIV-1 infection, and that FASN activity is required for a late step of HIV replication that is subsequent to viral protein expression (e.g. protein trafficking, virion assembly, or virion release). The goal of our proposed research is to determine how FASN activity and resulting de novo fatty acid (FA) production affect a late stage of HIV-1 replication. The product of FASN, palmitate, is a long chain FA that has multiple cellular roles, and can also be trimmed into myristate or extended into other long chain FAs. Long chain FAs have many cellular functions, including roles in membrane structure, energy storage, and regulation of subcellular protein localization. This proposal focuses on two plausible FASN-mediated mechanisms that could interrupt a late stage in the HIV-1 replication cycle: production of lipids for post-translational modification of proteins (AIM 1), and generation of FA to reconfigure cellular lipid composition (AIM 2). If HIV-1 requires FASN activity to facilitate viral protein trafficking or virion assembly, we will have revealed a fundamental mechanism that could explain why many enveloped viruses require FASN activity to replicate.

Key facts

NIH application ID
10082548
Project number
1R21AI141037-01A1
Recipient
OHIO STATE UNIVERSITY
Principal Investigator
JESSE J KWIEK
Activity code
R21
Funding institute
NIH
Fiscal year
2020
Award amount
$230,248
Award type
1
Project period
2020-06-15 → 2022-05-31